Since 1995, National HIV Testing Day has raised awareness and confronted stereotypes about HIV. Learn about HIV testing options and prevention methods.

The Metals Company (NASDAQ:TMC) stock is trading higher Wednesday after Wedbush upgraded the stock from a Neutral rating to an Outperform rating and raised its price target from $6 to $11.

Gilead’s daily antiviral pills can prevent HIV transmission and slow AIDS. While an HIV vaccine remains the Holy Grail, Gilead’s new long-lasting injection, lenacapavir, is the next best thing.

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

Elton John: We've made great progress on HIV/AIDS. Budget cuts threaten to set us back. Programs that provide treatment, fuel prevention and fight the stigma of HIV/AIDS should be expanded, not ...

MIT's new dual-adjuvant vaccine offers strong HIV protection with a single dose, potentially aiding in the fight against challenging viruses.

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new ...

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts ...

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to ...

A HIV physician expects a “majority” of her 125 PrEP users will switch to Gilead's newly approved Yeztugo within the next 12 months.